Background/Objectives: Children with celiac disease (CD) are at risk for decreased bone mineral density (BMD) because of fat-soluble vitamin malabsorption, inflammation and/or under-nutrition. The study objective was to determine the interrelationships between vitamin K/D status and lifestyle variables on BMD in children and adolescents with CD at diagnosis and after 1 year on the gluten-free diet (GFD). Subjects/Methods: Children and adolescents aged 3-17 years with biopsy proven CD at diagnosis and after 1 year on the GFD were studied. BMD was measured using dual-energy X-ray absorptiometry. Relevant variables included: anthropometrics, vitamin D/K status, diet, physical activity and sunlight exposure. Results: Whole-body and lumbar-spine BMD-z scores were low (pÀ1) at diagnosis (10-20%) and after 1 year (30-32%) in the children, independent of symptoms. Whole-body BMD-z scores (À0.55±0.7 versus 0.72±1.5) and serum levels of 25(OH) vitamin D (90.3 ± 24.8 versus 70.5 ± 19.8 nmol/l) were significantly lower in older children (410 years) when compared with younger children (p10 years) (Po0.001). Forty-three percent had suboptimal vitamin D status (25(OH)-vitamin D o75 nmol/l) at diagnosis; resolving in nearly half after 1 year on the GFD. Twenty-five percent had suboptimal vitamin K status at diagnosis; all resolved after 1 year. Conclusions: Children and adolescents with CD are at risk for suboptimal bone health at time of diagnosis and after 1 year on GFD; likely due in part to suboptimal vitamin D/K status. Therapeutic strategies aimed at optimizing vitamin K/D intake may contribute to improved BMD in children with CD.
Introduction
Celiac disease (CD) is the most common autoimmunemediated gastrointestinal (GI) disorder; occurring in approximately 1/100 individuals (Fasano and Catassi, 2001) . Genetically susceptible individuals exposed to gluten peptides have an inappropriate immune response that damages the small intestine mucosa (Fasano and Catassi, 2001) . While the classical presentation of CD is malabsorption and failure to thrive in an infant or toddler, more recently it has become recognized that CD can be present in individuals of all ages in the absence of GI or indeed any symptoms (Turner et al., 2009) . Screening for CD in the presence of risk factors, such as family history or type I diabetes, short stature, iron deficiency or idiopathic osteoporosis is warranted. Our previous clinical experience indicates that between 40 and 55% of symptomatic and asymptomatic children with CD had low bone mineral density (BMD) at diagnosis and that recovery after 1 year of treatment on the gluten-free diet (GFD) was incomplete; a worrisome finding given that critical bone accrual occurs during childhood and adolescence (Bailey, 1997; Turner et al., 2009; Rajani et al., 2010) .
The etiology of poor bone health in childhood CD is likely multi-factorial; relating to inadequate intake (vitamin D and K, calcium) , malabsorption, inflammation and other lifestyle variables (weight-bearing physical activity, medication use, sunlight exposure). The role of vitamin D deficiency in the etiology of low BMD in adults with CD remains controversial. Some studies report vitamin D levels to be in the normal range, however, clearly some individuals had vitamin D levels that would be considered a compromise to bone health (Ciacci et al., 1997; Mautalen et al., 1997; Lerner et al., 2011) . Secondary hyperparathyroidism, presumably due to intestinal malabsorption of calcium and/or vitamin D, seems to have an important role in the pathogenesis of bone loss in CD (Pazianas et al., 2005) . One of the larger prospective studies of bone density in adults, conducted over 3 years, showed more than one-quarter of subjects had secondary hyperparathyroidism at baseline, correlated with BMD, and this group was least likely to recover BMD at follow-up (Valdimarsson et al., 2000) . They also tended to have low vitamin D levels and some persistent intestinal damage despite reported compliance with a GFD. Ongoing minor intestinal damage, possibly from inadvertent gluten exposure, resulting in persistent calcium and vitamin D malabsorption and secondary hyperparathyroidism, is clearly a risk factor for low BMD in CD. In addition, it must be considered that peak bone mass accrual may have been compromised because of early onset, potentially silent disease, during childhood.
The role of vitamin K deficiency in the etiology of low BMD in CD has not been considered. This is despite our knowledge that a risk of vitamin K deficiency exists in CD (Cavallaro et al., 2004; Cashman, 2005) . Vitamin K has an important role in bone health, being essential for the carboxylation of proteins including the bone matrix protein osteocalcin (Booth, 1997; Cashman, 2005) . In those at risk, vitamin K deficiency increases fracture risk, while supplementation is protective (Cockayne et al., 2006) . There is increasing evidence that vitamin K has positive effects on calcium metabolism both independent and synergistic with vitamin D and this may be very relevant for the inadequately explained and persistent abnormalities in calcium metabolism observed in CD (Koshihara et al., 1996; Kobayashi et al., 2002) .
Prospective studies of bone mass accrual in children before diagnosis of CD and subsequent to the initiation of a GFD are lacking. Current knowledge is based principally on studies of adults and hence the pathogenesis of low BMD in CD in childhood remains incompletely understood. A few studies conducted in children with CD suggest that low BMD occurs in untreated CD and while bone may normalize on a GFD, this is more likely the earlier a diagnosis was made and the longer the duration of a GFD during childhood (Scotta et al., 1997; Kavak et al., 2003; Turner et al., 2009) . The objective of this study was to examine the potential interrelationships between vitamin D and K status and bone accrual and BMD at time of diagnosis and after 1 year on the GFD in children and adolescents with CD.
Subjects and methods

Subjects
In all, 54 children and adolescents (35 females and 19 males) between the ages of 3 and 17 years were screened for risk of CD by the gastroenterologist (JT) in the Multidisciplinary Celiac Clinic at the Stollery Children's Hospital, Edmonton, Alberta, Canada, before intestinal biopsy were recruited over a 10-to 12-month consecutive period. Out of these 54 patients, 52 children and their responsible caregivers agreed to participate. Only those with intestinal biopsies (n ¼ 43) diagnostic of CD, according to modified Marsh criteria (Marsh, 1992; Oberhuber et al., 1999) , were enrolled in this study at time of diagnosis and after 1 year (n ¼ 33) on the GFD (January-November, 2009 . Children with a history of co-morbid conditions known to influence vitamin K status (pancreatic insufficiency, short gut syndrome, hematologic or bone disorders) or to affect bone metabolism including endocrine, GI, renal or rheumatoid disorders (for example, type I diabetes, hyperparathyroidism, renal/liver disease) and/or taking medications known to interfere with either vitamin K (for example, warfarin) or bone metabolism (for example, phenytoin, non-steroidal anti-inflammatory drugs, oral glucocorticoids and oral contraceptives) were excluded from this study. Informed consent/assent was obtained from all subjects and/or their responsible caregivers before study entry. Ethics approval was obtained from the Human Research Ethics Board of the University of Alberta (UA).
Anthropometric variables
Weight was measured by an upright scale (Sunbeam Products, Inc., Pelstar LLC, Alsip, IL, USA) to the nearest 0.1 kg. Height was measured, without shoes, by using a wall mounted stadiometer (Holtain Ltd, Crymych, Dyfed, UK) to the nearest 0.1 cm. Body mass index was calculated for each patient according to the following equation body mass index ¼ weight (kg)/(height (m)) 2 . Weight-for-age, heightfor-age, body mass index z-scores were calculated using software Epi Info 3.5.1 (Atlanta, GA, USA) using Centre for Disease Control standards. Tanner staging was determined according to standard criteria by the gastroenterologist (Tanner and Whitehouse, 1976) .
Laboratory variables
Blood was collected at baseline (at time of intestinal endoscopy) and 1 year later for measurement of routine clinical blood work: 25(OH)-vitamin D, parathyroid hormone (PTH), calcium, magnesium, phosphorus and antitissue transglutaminase, and complete blood cell count after an overnight fast. These measurements were performed in the Core Laboratory at the UA Hospital according to standard methodologies. For purposes of analysis, any serum value of 25(OH)-vitamin D o50 nmol/l was considered deficient, 50-75 nmol/l as suboptimal and above 75 nmol/l sufficient vitamin D status (Holick, 2007) . An additional blood sample (B5 ml) was collected for assay of proteininduced in vitamin K absence-II (PIVKA-II) and bone turnover markers (bone-specific alkaline phosphatise (BAP), total osteocalcin and serum N-telopeptide type 1 collagen (NTX)). Plasma PIVKA-II concentration (abnormal values indicative of suboptimal vitamin K status 42 ng/ml) was measured by an enzyme-linked immunosorbent assay kit (Diagnostica Stago, Asnières, France). The intra-assay and inter-assay coefficient of variation for this assay were 8.8% and 10.3%, respectively (Mager et al., 2006) . Serum concentrations of BAP (Metra BAP; Quidel, San Diego, CA, USA), total osteocalcin (Quidel) and NTX (Osteomark NTX, Princeton, NJ, USA) were measured using commercial enzyme-linked immunosorbent assay kits. The intra-assay and inter-assay coefficients of variation for these kits were 4.4% and 5.7%, 2.5% and 1.8%, and 6.2% and 14.1% for BAP, total osteocalcin and NTX, respectively. BMD, bone mineral content (BMC) and bone age Whole-body and lumbar-spine BMD and BMC were measured using dual-energy X-ray absorptiometry scan by using Hologic QDR 4500A and Apex System 2.4.2 (Hologic Inc., Walham, MA, USA). BMD was defined by World Health Organization standards (BMD-z score pÀ2 indicative of osteoporosis) (Lewiecki et al., 2008) . For purposes of analysis, BMD-z scores pÀ1 were defined as increased risk for poor bone health. Bone age was measured according to standardized methodologies (Greulich and Pyle, 1959) .
Lifestyle variables: dietary intake, physical activity and sunlight exposure Three-day food intake records (2 weekdays, 1 weekend day) were collected. Subjects and/or their responsible caregivers were instructed how to record portion sizes, food type on standardized diet intake records. Micro-and macronutrient intake was determined using Food Processor (SQL 10.6 ESHA Research, Salem, OR, USA). Additional nutrient information from food labels were assessed to account for individual consumption of vitamin supplements or for variations in nutrient content of 'brand-name' products. Vitamin K content of individual foods was determined from the manufacturer food label, where available, and/or using the USDA database. Assessment of physical activity (Adolescent Physical Recall Questionnaire and FELS Questionnaire for children aged 6-12 years) and sunlight exposure was determined using validated questionnaires at diagnosis and after 1 year (Crocker et al., 1997; Termorshuizen et al., 2002; Treuth et al., 2005) .
Statistical analysis
Data are expressed as mean ± s.d. Univariate and multivariate analyses were performed to assess relationships between potential risk factors (age at diagnosis, presence of GI symptoms, bone turnover, vitamin K, D, calcium status/ intake, weight-bearing activity, sunlight exposure) on BMD and BMC. Variables shown to be associated with a low BMD was assessed using multivariate logistic regression models to assess risk for development of poor bone health in children and adolescents with CD. Non-parametric tests were utilized for variables demonstrating skewed distributions. Analysis of covariance was performed to adjust for any variables influencing primary outcome variables. Data analysis was completed using the SAS 9.0 statistical software (SAS, Version 9; SAS Institute, Cary, NC, USA). A value of Po0.05 was considered significant.
Results
Anthropometric and demographic data Anthropometric and demographic data are presented in Table 1 . A majority of children were 10 years of age or less (n ¼ 28 at diagnosis; n ¼ 17 at follow-up). Most children were growing at age-appropriate rates at diagnosis and 1-year follow-up (Tanner and Whitehouse, 1976) . Only two children had height-for-age and weight-for-age z-scores p2 at diagnosis; resolving in one child after 1 year (Tanner and Whitehouse, 1976) . Approximately, 53% (n ¼ 23) were symptomatic at time of presentation; all but three had complete resolution of GI symptoms after 1 year on GFD (Po0.01).
BMD, BMC and bone age Data regarding bone age, BMD and BMC are shown in Table 2 . Whole-body and lumbar-spine BMD (g/cm 2 ) and BMC (g) increased over the 1-year follow-up (P40.05). Although the percentage of children having a low wholebody BMD-z scores increased (10.7 to 20.8%), this was not a significant difference (P ¼ 0.78). No significant differences were noted in whole-body BMD/BMD-z/BMC or lumbar-spine BMD/BMD-z /BMC between symptomatic and non-symptomatic patients at diagnosis or after 1 year (P40.05). No significant relationships were found between the Marsh Criteria and these factors at diagnosis were noted (P40.05). Younger children had significantly higher wholebody BMD-z scores (p10 years; z: 0.7 ± 1.4) than older children (410 years; z: À0.5±0.7) (Po0.001) at time of diagnosis and after 1 year. No differences in lumbar-spine BMD-z scores were observed between younger and older children (P ¼ 0.35). Only one patient had a lumbar-spine BMD-z score oÀ2 at baseline and after 1 year. This patient had elevated anti-tissue transglutaminase levels and was positive for anti-endomysial antibodies.
Laboratory data related to vitamin status and bone turnover markers Biochemical data related to vitamin K, vitamin D, PTH, calcium, magnesium, phosphorus and bone turnover markers are presented in Table 3 . Twenty-three percent (10/43) of children had serum PIVKA-II concentrations indicative of vitamin K deficiency (42 ng/ml) at diagnosis; all normalized after 1 year. There were no significant differences in PIVKA-II levels between children with or Normal reference range: o2 ng/ml; (n ¼ 43 at diagnosis; n ¼ 30 after 1 year). d Normal reference range: 1.1-6.8 pmol/l; (n ¼ 38 at diagnosis; n ¼ 30 after 1 year).
e Normal reference range: 2.1-2.6 mmol/l; (n ¼ 38 at diagnosis; n ¼ 31 after 1 year). f Normal reference range: 0.7-1.0 mmol/l; (n ¼ 38 at diagnosis; n ¼ 31 after 1 year). g Normal reference range: 0.8-1.9 mmol/l; (n ¼ 38 at diagnosis, n ¼ 31 after 1 year). h Normal reference range: 60-139 U/l (3-14 years); (n ¼ 43 at diagnosis; n ¼ 29 after 1 year). i Normal reference range: 10-100 ng/ml (1-18 years) (66); (n ¼ 43 at diagnosis; n ¼ 29 after 1 year). j Normal reference range: 6-215 nM BCE/l (34); (n ¼ 43 at diagnosis; n ¼ 30 after 1 year). k Normal reference range: o7 U/ml (n ¼ 38 at diagnosis; n ¼ 31 after 1 year).
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Suboptimal vitamin D status was observed in 43% (14/34) children at diagnosis and in 25% (5/25) at 1-year follow-up (Po0.05). Only four children had 25(OH)-vitamin D levels o50 nmol/l at diagnosis, seven at the 1-year follow-up.
Serum 25(OH)-vitamin D was significantly higher after 1 year, particularly in children that were asymptomatic at diagnosis (79 versus 97 mmol/l) (Po0.05). Younger children (p10 years) had significantly higher concentrations of serum 25(OH)-vitamin D than older children (410 years) at both time points (Po0.001). Seasonal variations in 25(OH)-vitamin D levels were not a significant confounder (P40.05). Serum PTH was elevated in 43% (14/34) of children at diagnosis; resolving in all but one child after 1 year. More than 50% (8/14) of these children, had serum 25(OH)-vitamin D concentrations o75 nmol/l. No significant relationships were found between whole-body and lumbar-spine BMD/BMD-z/BMC and serum concentrations of 25(OH)-vitamin D and PTH.
Serum concentrations of BAP (bone formation) were elevated in 22/43 patients at diagnosis; all but 7 returned to normal after 1 year (P40.05). In contrast, serum concentrations of NTX (bone resorption) decreased significantly after 1 year; all were within normal reference ranges, except for one child at diagnosis (Po0.05). All children had elevated levels of anti-tissue transglutaminase and were positive for anti-endomysial antibodies at diagnosis; only two children had elevated anti-tissue transglutaminase levels after 1 year. Concentrations of the remaining laboratory variables were within normal reference ranges.
Lifestyle variables: diet, physical activity and sunlight exposure Diets were characterized by macronutrient distributions within the acceptable macronutrient distributions for age and gender (Table 4) . In all, 90% (n ¼ 20) of patients did not have dietary intakes that met the estimated average requirement for vitamin D for age and gender at diagnosis; none met the estimated average requirement at 1-year follow-up (Ross et al., 2011) . In contrast, 40.9% (n ¼ 9) and 31% (n ¼ 5) had vitamin K intakes that were o50% of the adequate intake at diagnosis and after 1 year; the remaining had intakes approximating the adequate intake for age and gender (Otten et al., 2006) . There was a trend toward increasing vitamin K intake on the GFD (P ¼ 0.06). Dietary calcium intake was less than the estimated average requirement in 64% of patients at diagnosis (n ¼ 14) and in 69% (n ¼ 11) after 1 year (Ross et al., 2011) . There were no significant differences in intake of these nutrients between younger (p10 years) versus the older children (410 years RDA: 1-18 years, 80-360 mg/day. f RDA: 1-18 years, 460-1250 mg/day. g AI: 1-18 years, 1000-1500 mg/day; P ¼ 0.065. h No more than 45-85 mg/day for 7-12 years; 2.5 mg/kg body weight for 13-18 years (Health Canada: http://www.hc-sc.gc.ca/hl-vs/iyh-vsv/food-aliment/caffeineeng.php#he).
Relationships between lifestyle variables and BMD and bone turnover markers
No relationships between vitamin D and calcium intake and markers of bone health (BMC, BMD/BMD-z) were observed at diagnosis or after 1 year on the GFD; consistent with the over-all low intakes of vitamin D and calcium. In contrast, increasing vitamin K (P ¼ 0.003) and protein (Po0.001) intakes were correlated with increasing wholebody and lumbar-spine BMC at diagnosis and after 1 year. These relationships were consistent with changes in bone turnover markers: increasing BAP and decreasing NTX (Po0.05). Although our subjects reported age appropriate levels of outdoor activities with coinciding weight-bearing activities, no significant relationships between these parameters and the markers of bone health were detected (Tremblay et al., 2011a, b) .
Discussion
This study is a comprehensive study that included the assessment of BMD (whole-body/lumbar-spine), bone turnover, anthropometrics, clinical variables related to growth and GI symptoms along with an evaluation of lifestyle factors (diet, physical activity and sunlight exposure) known to influence overall bone status in a population of children and adolescents newly diagnosed with CD. In CD, there are several potential explanations for the etiology of poor bone health. These include the potential for chronic malabsorption of nutrients known to influence bone formation (vitamins D, K and calcium), decreased dietary intake because of the presence of significant GI symptoms (diarrhea, anorexia) or the presence of chronic inflammation, which is known to influence bone metabolism by depressing bone synthesis and upregulating bone resorption (Sylvester et al., 2007) . Other factors known to influence overall bone health include reductions in endogenous synthesis in vitamin D because of poor sunlight exposure, particularly in those living in northern climates and changes in weightbearing activity (Roth et al., 2005) . However, little is known about the extent to which all of these factors may influence overall bone accrual in children and adolescents with CD, particularly those with seemingly normal growth living in a northern climates (Roth et al., 2005; Genuis et al., 2009) . We hypothesized that overall bone health and bone accrual in children with CD would be directly influenced by vitamin K and D status, independent of symptoms.
In this study, we showed that approximately 10-30% of the children and adolescents diagnosed with CD have low lumbar-spine and whole-body BMD-z scores at diagnosis and after 1 year on the GFD. This occurred in a population of relatively young children with seemingly normal growth and nutritional status, independent of the presence or absence of GI symptoms at time of diagnosis. Interestingly, the risk for poor bone health did not change after 1 year on the GFD, but was significantly higher in older children and adolescents (410 years), indicating that time to diagnosis is an important factor to bone health in CD (Motta et al., 2009; Blazina et al., 2010) . In addition, it shows that the length of time to recover suboptimal bone accrual in children with CD exceeds 1 year, even with compliance to dietary treatment. This occurred in the presence of low dietary intakes of vitamin K, calcium and vitamin D at diagnosis and after 1 year in both the younger (p10 years) and older children (410 years) despite no apparent differences in dietary intake of these nutrients in these age groups. While seasonal variations in serum vitamin D levels were not observed, this may have contributed to the higher prevalence of decreased BMD/diminished bone accrual in the older children. These children had persistently lower serum levels of vitamin (o70 nmol/l); all of which would have contributed to diminished bone accrual over the 1 year on the GFD. In addition, many of these children had elevated serum PTH levels, which would have also contributed to diminished bone accrual.
Although most children had vitamin D and calcium intakes that were significantly lower than recommended levels, no significant relationships between these nutrients and the markers of bone health measured were observed (Roth et al., 2005; Ross et al., 2011) . This is likely due to the fact that intake of these nutrients did not significantly increase on the GFD and remained persistently low, a finding that is supported within the literature, particularly in Canada where intakes of vitamin D are generally low in healthy children and adolescents (El Hayek et al., 2010; Ohlund et al., 2010; Wild et al., 2010; Mark et al., 2011) . Although a few children were taking a vitamin supplement (n ¼ 5), these were consumed on an ad hoc basis, and likely did not contribute sufficiently to overall vitamin D/calcium nutriture and bone health. Recent evidence indicates that vitamin D insufficiency in CD is age dependent rather than related specifically to degrees of intestinal damage; with increased risk for insufficiency related to increasing age, particularly in adults (Lerner et al., 2011) . Our data are consistent with this finding, and points to the need for careful consideration for routine daily supplementation in vitamin D and calcium in children with CD, even in those with apparent global nutritional adequacy. This is particularly evident in children and adolescents living in northern climates like Alberta, where vitamin D insufficiency in the general population in this age group is thought to approximate at least 30-40% of the population (Roth et al., 2005; Genuis et al., 2009) . Given that all of the children had dietary intakes of calcium and vitamin D intakes well below the recommended levels, routine supplementation at time of diagnosis of CD to at least the recommended daily allowance appears warranted in children and adolescents with CD (Ross et al., 2011) .
There are limited available data that relate the role of vitamin K and bone health in children and adults with CD. However, the role of vitamin K in bone health in healthy adults and children has been extensively studied (Booth, 1997; Valdimiarsson et al., 2000) . It has been demonstrated in a recent study that better vitamin K status is related to increased whole-body bone mass in healthy pre-pubertal children (Pazianas et al., 2005) . One study examined vitamin K status in children newly diagnosed with CD using prothrombin times as a marker of vitamin K status and found that approximately 35% of children were deficient by this marker (Pazianas et al., 2005) . However, this may have been an underestimate of the prevalence of vitamin K deficiency as prothrombin time is a very insensitive marker of overall vitamin K status (Pazianas et al., 2005) . More sensitive markers of vitamin K status include serum levels of PIVKA-II and/or undercarboxylated osteocalcin, both of which are vitamin Kdependent proteins (Booth, 1997; Valdimiarsson et al., 2000) . Although over 25% the children were vitamin K deficient at diagnosis, this resolved in all children after 1 year. This appeared to be due in part to improvements in vitamin K intake on the GFD. However, a remaining one-third of children and adolescents continued to have vitamin K intakes considerably lower than the adequate intake on the GFD and had whole-body BMD-z scores below minus 1; all pointing to suboptimal vitamin K status as a potential contributing factor to persistent poor bone health in childhood CD.
The major limitations in this study is the inability to differentiate how some lifestyle factors (physical activity and sunlight exposure) specifically contributed to poor bone health, given the smaller sample size. In addition, given the absence of a population control group it is challenging to differentiate between the lifestyle factors that may be contributing to poor bone health, independent of the CD; requiring further investigation. This is particularly true of dietary vitamin D intake; however, the additional risk of malabsorption in the CD population highlights a need to address this risk factor for the CD population. At the current time, we do not know if this can be achieved by a GFD alone, certainly our study would suggest that is not the case.
Conclusion
Both asymptomatic and symptomatic children and adolescents with CD are at risk for suboptimal bone health at time of diagnosis and after 1 year, despite apparent age appropriate rates of growth and compliance with a GFD. Suboptimal vitamin D and K status may contribute to an increased risk for poor bone health in childhood CD. Furthermore, suboptimal dietary intake of vitamins D, vitamin K and calcium are common in this population, including when on a GFD. Careful consideration should be given to routine supplementation of these nutrients at time of diagnosis of CD. Vitamin D is a nutrient of particular concern, particularly in northern climates such as Alberta. Given that childhood and adolescence are a critical period for bone growth and deposition, it remains imperative that monitoring of bone health in children with CD is part of routine clinical assessment. In order to maximize bone health for children, CD early diagnosis is likely to be important and requires awareness of atypical and asymptomatic presentations; particularly as risk factors for poor bone health are equivalent regardless of symptoms presentation.
